HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Outcome of Prompt Concomitant Single-Dose High-Concentration Intratympanic and Tapered Low-Dose Oral Systemic Corticosteroid Treatment for Sudden Deafness.

AbstractOBJECTIVES:
To investigate the efficacy of prompt concomitant corticosteroid treatment with single application of high-concentration intratympanic (IT) dexamethasone and tapered low-dose systemic methylprednisolone of an idiopathic sudden sensorineural hearing loss (ISSNHL).
MATERIALS AND METHODS:
Between September 2017 and September 2019, 86 adult patients met the criteria for the diagnosis of ISSNHL at baseline evaluation. The patients received immediate concomitant treatment with single high-concentration (24 mg/mL) IT dexamethasone and low-dose (48 mg) oral methylprednisolone for 1 week followed by tapered doses. Improvement in pure-tone average (PTA) and word recognition score (WRS) was determined after 1 and 6 months.
RESULTS:
A total of 63 patients met the requirements for the analysis. PTA improved in 71% and WRS improved in 59% of patients with ISSNHL. PTA and WRS were statistically significantly different at different time points during the intervention (p<0.0005). Hearing improved in all measured frequencies from 125 to 8000 Hz until the second follow-up. In 65.4% of patients with tinnitus, the WRS has improved compared with 27.3% without tinnitus (p<0.05). In 69.2% of patients without vertigo, the WRS has improved compared with 41.7% with vertigo (p<0.05).
CONCLUSION:
Prompt concomitant single high-concentration IT and low-dose systemic corticosteroid treatment is efficient in recovering hearing loss and speech discrimination in ISSNHL. Tinnitus positively predicts hearing outcome. Vertigo negatively predicts speech discrimination recovery.
AuthorsŠpela Kordiš, Domen Vozel, Manja Hribar, Nina Božanić Urbančič, Saba Battelino
JournalThe journal of international advanced otology (J Int Adv Otol) Vol. 16 Issue 2 Pg. 201-206 (Aug 2020) ISSN: 2148-3817 [Electronic] Turkey
PMID32784158 (Publication Type: Journal Article)
Chemical References
  • Glucocorticoids
  • Dexamethasone
  • Methylprednisolone
Topics
  • Audiometry, Pure-Tone
  • Dexamethasone (administration & dosage)
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids (administration & dosage)
  • Hearing (drug effects)
  • Hearing Loss, Sudden (drug therapy)
  • Humans
  • Injection, Intratympanic
  • Male
  • Methylprednisolone (administration & dosage)
  • Middle Aged
  • Prospective Studies
  • Speech Perception
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: